bone
News/ News/ Sales and Marketing
Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
X
Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
https://pharmaphorum.com/news/inozyme-plans-75-ipo-as-it-heads-for-clinic-with-rare-bone-diseases-drug/
US regulator approves new use for Amgen bone drug
Richard Staines
Amgen, blood cancer, bone, cancer, multiple myeloma, Novartis
0 Comment
New use in multiple myeloma for Xgeva
X
US regulator approves new use for Amgen bone drug
https://pharmaphorum.com/news/us-regulator-approves-new-use-amgen-bone-drug/
Amgen’s Prolia succeeds in glucocorticoid-induced osteoporosis
Richard Staines
Amgen, bone, fracture, osteoporosis, R&D
0 Comment
Possible new use for well-established drug.
X
Amgen’s Prolia succeeds in glucocorticoid-induced osteoporosis
https://pharmaphorum.com/news/amgens-prolia-succeeds-glucocorticoid-induced-osteoporosis/